Concepedia

Nicholaos Bellos

NB

Statistics

Publications

15

Citations

1.8K

H-Index

15

Active since

2000

Affiliations

Infectious Disease Consultants(Current)

Orlando Immunology Center

Thomas Jefferson University

Research Triangle Park Foundation

GlaxoSmithKline (United States)

Nicholaos Bellos is an author at Infectious Disease Consultants specializing in antiviral therapy, antiviral pharmacotherapy, and antiretroviral therapy.

Publications per year

2000–2023

15

Publications

15

Subgroup Analyses of Maraviroc in Previously Treated R5 HIV-1 Infection

Gerd Fätkenheuer, Mark Nelson, Adriano Lazzarin et al. · New England Journal of Medicine · 2008 · 361 citations · Full text

, , +17

Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment

Kimberly Y. Smith, Parul Patel, Derek M. Fine et al. · AIDS · 2009 · 217 citations

, , +17

Tenofovir Disoproxil Fumarate in Nucleoside-Resistant HIV-1 Infection

Kathleen Squires, Anton Pozniak, Gerald Pierone et al. · Annals of Internal Medicine · 2003 · 199 citations

, , +17

SOLO

Joseph Gathe, Prudence Ive, Robin Wood et al. · AIDS · 2004 · 196 citations

, , +17

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax et al. · The Lancet HIV · 2018 · 145 citations

, , +10

1–5 of 15